Peter M. Hecht
2013 - Ironwood Pharmaceuticals
In 2013, Peter M. Hecht earned a total compensation of $2.4M as Chief Executive Officer at Ironwood Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,302,688 |
|---|---|
| Salary | $100,000 |
| Other | $7,440 |
| Total | $2,410,128 |
Hecht received $2.3M in option awards, accounting for 96% of the total pay in 2013.
Hecht also received $100K in salary and $7.4K in other compensation.
Rankings
In 2013, Peter M. Hecht's compensation ranked 3,245th out of 12,286 executives tracked by ExecPay. In other words, Hecht earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,245 out of 12,286 | 74th |
Division Manufacturing | 1,099 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 286 out of 1,462 | 80th |
Industry group Drugs | 196 out of 1,156 | 83rd |
Industry Pharmaceutical Preparations | 163 out of 890 | 82nd |
Source: SEC filing on April 15, 2016.
Hecht's colleagues
We found three more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2013.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019